Neumora Therapeutics Inc.’s stock tumbled 81% Thursday after the clinical-stage biotech said a late-stage trial of a ...

Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced the initiation of a Phase 2 ...

Up to 12 months, psychological interventions showed preventive effects for major depressive disorder reducing symptom severity and incidence.

High-functioning depression masks inner struggles behind normalcy. Learn how subtle symptoms, societal pressure, and stigma ...

The holidays are over, and for many Minnesotans, the end of the festive season can bring on a familiar feeling of winter blues. But for some, seasonal shifts can trigger ...

Treating ADHD is straightforward with stimulants, often giving patients life-changing relief. But with comorbid conditions, ...

Older adults with major depression exhibit unique patterns of risky driving independent of antidepressant use, suggesting the need for targeted interventions to ensure safety.

Adolescents may experience delayed bipolar disorder (BD) progression after major depressive disorder (MDD) diagnosis.

Unlike major depressive disorder, seasonal affective disorder usually lasts anywhere from a couple of weeks to a few months.

Navacaprant is an highly selective kappa opioid receptor antagonist expected to modulate reward processing pathways and mediate depressive states.

In this longitudinal cohort study of older drivers, adults with major depressive disorder demonstrated distinct and riskier driving behaviors than those in the control group without depression, with ...